CRISPR-Based Diagnostics Market Size to Hit USD 15.14 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on CRISPR-Based Diagnostics Market

5.1. COVID-19 Landscape: CRISPR-Based Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global CRISPR-Based Diagnostics Market, By Product Type

8.1. CRISPR-Based Diagnostics Market Revenue and Volume, by Product Type

8.1.1. Kits & Assays

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Instruments & Devices

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Software & Data Analytics Tools

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Services

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global CRISPR-Based Diagnostics Market, By Technology/CRISPR Platform

9.1. CRISPR-Based Diagnostics Market Revenue and Volume, by Technology/CRISPR Platform

9.1.1. Cas12-Based Diagnostics

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Cas13-Based Diagnostics

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cas9-Based Diagnostics

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Other Novel Cas Enzymes

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global CRISPR-Based Diagnostics Market, By Detection Method/Readout

10.1. CRISPR-Based Diagnostics Market Revenue and Volume, by Detection Method/Readout

10.1.1. Fluorescence-Based Detection

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Lateral Flow Assays

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Electrochemical Detection

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Snacks

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Optical & Imaging-Based Detection

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global CRISPR-Based Diagnostics Market, By Application

11.1. CRISPR-Based Diagnostics Market Revenue and Volume, by Application

11.1.1. Infectious Disease Detection

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Oncology Biomarker Testing

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Genetic Disorder Screening

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Prenatal & Neonatal Diagnostics

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Agricultural Pathogen Detection

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global CRISPR-Based Diagnostics Market, By Distribution Channel

12.1. CRISPR-Based Diagnostics Market Revenue and Volume, by Distribution Channel

12.1.1. Direct Sales to Hospitals, Labs & Research Centers

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Distributors & Channel Partners

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Online Platforms & E-Commerce

12.1.3.1. Market Revenue and Volume Forecast

Chapter 13. Global CRISPR-Based Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.1.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.1.6.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.1.7.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.2.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.2.4. Market Revenue and Volume Forecast, by Application

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.2.6.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.2.7. Market Revenue and Volume Forecast, by Application

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.2.9.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.2.12.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.2.14.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.3.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.3.6.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.3.8.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.3.10.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.3.11.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.4.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.4.6.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.4.8.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.4.10.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.4.11.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.5.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.5.6.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Technology/CRISPR Platform

13.5.8.3. Market Revenue and Volume Forecast, by Detection Method/Readout

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 14. Company Profiles

14.1. Caspr Biotech

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. CRISPR Diagnostics Ltd.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Inscripta

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Synthego Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Danaher Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Thermo Fisher Scientific Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Merck KGaA

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Agilent Technologies

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Bio-Rad Laboratories

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Ginkgo Biowork

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The CRISPR-based diagnostics market size is expected to increase from USD 3.79 billion in 2025 to USD 15.14 billion by 2034.

The CRISPR-based diagnostics market is expected to grow at a compound annual growth rate (CAGR) of around 16.63% from 2025 to 2034.

The major players in the CRISPR-based diagnostics market include Caspr Biotech, CRISPR Diagnostics Ltd. Inscripta, Synthego Corporation, Danaher Corporation, Thermo Fisher Scientific Inc, Merck KGaA, Merck KGaA, and Bio-Rad Laboratories

The driving factors of the CRISPR-based diagnostics market are the increasing demand for accurate diagnostics and point-of-care testing, as well as growing innovations and the application of CRISPR-based diagnostics.

North America region will lead the global CRISPR-based diagnostics market during the forecast period 2025 to 2034.